Chronic Rhinosinusitis Trial, Not Yet Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with chronic rhinosinusitis with nasal polyps (a condition where the sinuses are chronically inflamed and nasal polyps have grown), confirmed using standard medical guidelines
- Your nasal polyps show a high level of a specific type of immune cell (eosinophils make up more than 27% of the cells found in the tissue)
- OR you are having surgery to straighten a deviated nasal septum (a crooked wall inside the nose) and have no other nasal conditions — this would be as a comparison/control participant
- You have stopped taking steroid medications (whether swallowed or inhaled as a spray) and leukotriene-blocking medications for at least 4 weeks before your biopsy or surgery
Who may not be able to join:
- You have been diagnosed with any of the following: polyps in the back of the upper jaw sinus, cystic fibrosis, fungal sinus infection, a condition affecting how the tiny hairs in your airways move (primary ciliary dyskinesia), hay fever/allergic rhinitis, a weakened immune system, or a blood clotting disorder
- You have a sensitivity or intolerance to aspirin that causes nasal/respiratory symptoms (sometimes called AERD or aspirin-exacerbated respiratory disease)
- You are a smoker
- You are pregnant
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lei Cheng, The First Affiliated Hospital, Nanjing Medical University
Phone: 0086-13776620807
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Nasal polyp size after glucocorticosteroid; endoscopic evidence of returned polyposis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.